Mgr. Mária Krchniaková, Ph.D.
Researcher II, Section of Genetics and Molecular Biology
office: bldg. C13/313
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 8453 |
|---|---|
| e‑mail: |
Total number of publications: 12
2025
-
Depleting chemoresponsive mitochondrial fission mediator DRP1 does not mitigate sarcoma resistance
Life Science Alliance, year: 2025, volume: 8, edition: 2, DOI
2023
-
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma
Cell Death and Disease, year: 2023, volume: 14, edition: 11, DOI
2022
-
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 1, DOI
-
Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells
Frontiers in Pharmacology, year: 2022, volume: 13, edition: September, DOI
-
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 15, DOI
2021
-
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Antioxidants, year: 2021, volume: 10, edition: 11, DOI
2020
-
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
International Journal of Molecular Sciences, year: 2020, volume: 21, edition: 9, DOI
2016
-
Analysis of anti-tumour and anti-viral reactivities of human gamma-delta T cells
Year: 2016, type: Appeared in Conference without Proceedings
-
Analysis of gamma-delta T cells and plasmacytoid dendritic cells in MGUS and Multiple Myeloma patients
Year: 2016, type: Appeared in Conference without Proceedings
-
Analysis of the EphA2 Receptor Expression on Malignant Plasma Cells and Plasmacytoid Dendritic Cells in MGUS and Multiple Myeloma Patients
Year: 2016, type: Appeared in Conference without Proceedings